Translational Development Acquisition Corp.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
TDAC$10.87+0.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
| | | | | | | |
|---|---|---|---|---|---|---|
| · · For the Year Ended December 31, | ||||||
| | 2024 | 2023 | ||||
| Cash Flows from Operating Activities: | | | | | | |
| Net loss | | $(71,012) | | $(485,550) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | ||||
| Payment of operation costs through promissory note | | 4,719 | | |||
| Dividends earned on marketable securities held in Trust Account | | (125,346) | | — | ||
| Write-off of deferred offering costs to earnings | | — | | 482,340 | ||
| Changes in operating assets and liabilities: | | | ||||
| Other receivable | | — | | — | ||
| Prepaid expenses | | (212,059) | | 2,000 | ||
| Due to Sponsor | | 2,000 | | — | ||
| Accounts payable and accrued expenses | | (449,748) | | 1,006 | ||
| Net cash used in operating activities | | (851,446) | | (204) | ||
| | | | | | | |
| Cash Flows from Investing Activities: | | | ||||
| Investment of cash in Trust Account | | (174,225,000) | | — | ||
| Net cash used in investing activities | | (174,225,000) | | — | ||
| | | | | | | |
| Cash Flows from Financing Activities: | | | ||||
| Proceeds from sale of Units, net of underwriting discounts paid | | 169,050,000 | | — | ||
| Proceeds from sale of Private Placements Warrants | | 7,075,000 | | — | ||
| Proceeds from promissory note - related party | | 406,540 | | — | ||
| Repayment of promissory note - related party | | (800,000) | | — | ||
| Payment of offering costs | | (218,941) | | — | ||
| Net cash provided by financing activities | | 175,512,599 | | — | ||
| | | | | | | |
| Net Change in Cash | | 436,153 | | (204) | ||
| Cash – Beginning of year | | 2,021 | | 2,225 | ||
| Cash – End of year | | $438,174 | | $2,021 | ||
| | | | | | | |
| Non-Cash investing and financing activities: | | | ||||
| Offering costs included in accrued offering costs | | $495,872 | | $5,830 | ||
| Deferred offering costs paid through promissory note – related party | | $41,241 | | $88,500 | ||
| Remeasurement of carrying value to redemption value | | $13,118,973 | | $— | ||
| Deferred underwriting fee | | $6,037,500 | | $— | ||
| Offering costs charged to additional paid in capital | | $756,054 | | $— | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.